Background illustration for clinical trials search

Paid Clinical Trials Rochester

Discover 440 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Oswego NY, Syracuse NY, Verona NY, Hershey PA,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase 2, Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Oswego NY, Buffalo NY, Syracuse NY, Verona NY, Erie PA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase 3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: Oswego NY, Buffalo NY, Syracuse NY, Sayre PA, Verona NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase 3, Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Oswego NY, Syracuse NY, Verona NY, Beachwood OH,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase 2, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Williamsville NY, New York NY, Long Island City NY,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07018323

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Torrington CT, Cumberland MD, Westminster MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Patient Retrospective Outcomes (PRO)

for
Chronic Pain
Location: Williamsville NY, Cleveland OH, The Bronx NY, Toledo OH,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT01550575

Recruiting
Active & Responsive

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

for
Ovarian Cancer
Location: Rochester NY, Morristown NJ, Providence RI,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 50 - 70+

Code: NCT00539162

Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Location: Rochester NY, Liverpool NY, Erie PA, Beachwood OH,
Sponsor: Adverum Biotechnologies, Inc.

Sex: All

Age: 50+

Code: NCT07482176

Phase 3, Recruiting

Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy

for
Diabetes Mellitus,
Location: Rochester NY, Johnson City NY, Altoona PA, Johnston RI,
Sponsor: Analgesic Solutions

Sex: All

Age: 18+

Code: NCT01770964

Recruiting

A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD Patients

for
Atopic Dermatitis
Location: Rochester NY, New York NY
Sponsor: DermTech

Sex: All

Age: 1+

Code: NCT04699695

Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Rochester NY, Syracuse NY, Toronto, London, Hershey PA,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

for
Sarcoma
Location: Rochester NY, Buffalo NY, Syracuse NY, Toronto,
Sponsor: University of Leicester

Sex: All

Age: 0 - 49

Code: NCT00020566

Phase 3, Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for
Geographic Atrophy (GA),
Location: Rochester NY, Liverpool NY, Toronto, Erie PA, London,
Sponsor: ONL Therapeutics

Sex: All

Age: 55+

Code: NCT06659445

Phase 2, Recruiting

A Study of MF101 in Postmenopausal Women

for
Hot Flushes, Vasomotor Symptoms
Location: Rochester NY, Pittsburgh PA, Cleveland OH,
Sponsor: Bionovo

Sex: Female

Age: 40 - 65

Code: NCT00906308

Phase 3, Recruiting

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

for
Healthy Volunteers, Influenza
Location: Rochester NY, Charlottesville VA, Oak Brook IL,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07779408

Phase 1, Phase 2, Recruiting

Longitudinal Endpoint Assessment of Disease Burden in HD

for
Huntington Disease
Location: Rochester NY
Sponsor: Huntington Study Group

Sex: All

Age: 18+

Code: NCT06475898

Recruiting

Effect of Blue Light Glasses on Screen Usage After a Concussion in College Students

for
Brain Concussion
Location: Rochester NY
Sponsor: Rochester Institute of Technology

Sex: All

Age: 18 - 26

Code: NCT04804501

Recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

for
Cutaneous Lupus Erythematosus (CLE),
Location: Fairport NY, Troy MI, Flint MI, Indianapolis IN,
Sponsor: Ventus Therapeutics U.S., Inc.

Sex: All

Age: 18 - 70+

Code: NCT07260877

Phase 2, Recruiting

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

for
Atopic Dermatitis
Location: E. Amherst NY, Toronto, Hamilton, Ottawa,
Sponsor: ASLAN Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05694884

Phase 2, Recruiting